A phase II study of perioperative concurrent chemotherapy, gefitinib, and hyperfractionated radiation followed by maintenance gefitinib in locoregionally advanced esophagus and gastroesophageal junction cancer (Q43222301)
Jump to navigation
Jump to search
scientific article published in February 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study of perioperative concurrent chemotherapy, gefitinib, and hyperfractionated radiation followed by maintenance gefitinib in locoregionally advanced esophagus and gastroesophageal junction cancer |
scientific article published in February 2010 |
Statements
1 reference
A phase II study of perioperative concurrent chemotherapy, gefitinib, and hyperfractionated radiation followed by maintenance gefitinib in locoregionally advanced esophagus and gastroesophageal junction cancer (English)
1 reference
Cristina P Rodriguez
1 reference
David J Adelstein
1 reference
Thomas W Rice
1 reference
Lisa A Rybicki
1 reference
Gregory M M Videtic
1 reference
Jerrold P Saxton
1 reference
Sudish C Murthy
1 reference
David P Mason
1 reference
Denise I Ives
1 reference
1 February 2010
1 reference
1 reference
Identifiers
1 reference